Colonoscopy
Colonoscopy has been studied in 176 papers since 2003: 11 trials and 85 observational studies in people, 62 reviews; 123 in the past year. The newest paper, Nov 18, 2026: “National guidelines for colorectal cancer screening in Saudi Arabia: Recommendations from the multi-society guideline development task force”.
16 new papers in 30 daysSee all 176 papers on colonoscopy
At a glance
Colonoscopy is linked with lower mortality in human studies from independent labs, but a propensity-matched screening analysis finds no clear mortality link. Colorectal cancer links range from lower to higher risk or no clear association across screening and surveillance studies; independent labs also report perforation associations. Two of 10 papers declare company ties; some authors work at Samsung companies.
53 findings in 36 papers from 2005 to 2026, 14 of them since April 2026
Independent labs found the same change in people. 17 independent labs in 10 countries.
“The observed reductions in CRC-related mortality and CRC incidence, which were consistent across both screening strategies, were independent of sex or age.”
7 of its findings point the other way.
- 17 independent labs in 10 countries
- 7 findings against
- Funders: National Cancer Institute and others
- 6 of 32 findings with company ties
- Human trial11
- Humans85
- In silico18
Studies in people
1 study gave colonoscopy to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
| Randomized trial | Both50-69 yearsMidlife adults; Older adults; healthy adults | United European gastroenterology journal, Feb 20, 2026 |
What did studies of colonoscopy find?
7Studies of colonoscopy measured 7 outcomes; the most studied are mortality (6 studies), colorectal cancer (5) and colorectal cancer mortality (3).
Mortality
downin humans4no changein humans1downin silico1−61%HR 1.01
6 studies
Mortality
downin humans4no changein humans1downin silico1−61%HR 1.01
Colonoscopy was not clearly linked with mortality in humans (Propensity-matched adults with a colorectal cancer screening encounter) (HR 1.01, 95% CI 0.97–1.05).
“Five-year all-cause mortality was unchanged (HR 1.01 [0.97-1.05]; p = 0.741).”
HumansPropensity-matched adults with a colorectal cancer screening encounterscreening5 years
Colonoscopy linked to more cancer detection in older adults
JGH open : an open access journal of gastroenterology and hepatology
Colonoscopy is linked with lower mortality in humans (surveillance at a mean interval of ≤3 years).
“Surveillance at a mean interval of ≤3 years (n=3028) was associated with a decrease in CRC-specific and all-cause mortality”
Humanssurveillance at a mean interval of ≤3 yearsn = 3,028
Gut
Colonoscopy decreases mortality in humans.
“polypectomy substantially reduces CRC incidence and mortality.”
Review
Screening for Colorectal Cancer with Colonoscopy
Gastrointestinal endoscopy clinics of North America
Colonoscopy decreases mortality in silico (95.3% (95% CI = 93.8% - 96.5%)).
“and 95.3% (95% CI = 93.8% - 96.5%) of CRC mortality.”
In silico
Model predicts a shift in colon cancer origins with screening
Journal of the National Cancer Institute
Colonoscopy decreases mortality in humans (>30%).
“Colonoscopy screening, proven globally to reduce mortality by over 30%, represents an underutilized intervention”
Review
Strengthening colonoscopy screening in primary care: A preventive imperative before the coming surge
Journal of family medicine and primary care
Colonoscopy decreases mortality in humans (61%).
“Colonoscopy lowers mortality by 61%”
Review
Current Perspectives on Colorectal Cancer Screening and Surveillance in the Geriatric Population
Current gastroenterology reports
Colorectal cancer
downin silico2no changein humans1downin humans1downin reviews1−26%
5 studies
Colorectal cancer
downin silico2no changein humans1downin humans1downin reviews1−26%
Colonoscopy was not clearly linked with colorectal cancer in humans (surveillance at a mean interval of ≤3 years).
“without an associated change in total CRC incidence, even after multivariate adjustment”
Humanssurveillance at a mean interval of ≤3 yearsn = 3,028
Gut
Colonoscopy decreases colorectal cancer in silico (simulated relative to no screening) (26%).
“Relative to no screening, colonoscopy and FIT reduced late-stage diagnoses by 26% and 25%, respectively, versus 20%-32% for annual MCED screening.”
In silicosimulated relative to no screening
medRxiv : the preprint server for health sciencesPreprint
Colonoscopy prevents colorectal cancer in humans (through precancerous lesion detection and removal).
“Colonoscopy remains the most comprehensive screening modality, enabling the detection and removal of precancerous lesions, thereby preventing the development of CRC.”
Reviewthrough precancerous lesion detection and removal
Clinical endoscopy
Colonoscopy prevents colorectal cancer in silico (93.9% (95% CI = 92.0% - 94.3%)).
“Screening was predicted to prevent 93.9% (95% CI = 92.0% - 94.3%) of CRC”
In silico
Model predicts a shift in colon cancer origins with screening
Journal of the National Cancer Institute
Colonoscopy prevents colorectal cancer.
“Colonoscopy prevents colorectal cancer through polyp detection and resection.”
Review
Ensuring High-Quality Colonoscopy: A Review
Gastrointestinal endoscopy clinics of North America
Colorectal cancer mortality
downin humans2downin silico1
3 studies
Colorectal cancer mortality
downin humans2downin silico1
Colonoscopy decreases colorectal cancer mortality in humans.
“evidence supports colonoscopy's ability to reduce population-wide colorectal cancer mortality”
Review
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Colonoscopy decreases colorectal cancer mortality in Lynch syndrome.
“colonoscopic surveillance in LS reliably reduces CRC mortality”
Reviewin Lynch syndrome
Colonoscopy surveillance in Lynch syndrome: what it prevents and what it does not
Journal of medical genetics
Colonoscopy decreases colorectal cancer mortality in silico (healthy) (42 people needed to screen to prevent one cancer-related death).
“One cancer-related death would be prevented by screening 42 healthy men aged 70-74 years with colonoscopy”
In silicohealthyevery 10 yearsmales
Comparing risks and benefits of colorectal cancer screening in elderly patients
Gastroenterology
Lifespan
upin silico1
1 study
Lifespan
upin silico1
Colonoscopy improves lifespan in silico (colonoscopy at age 40/50/60/70) (449 LYG per 1000 individuals).
“The most effective colonoscopy-based screening strategy is colonoscopy at age 40/50/60/70 (449 LYG per 1000 individuals)”
In silicocolonoscopy at age 40/50/60/70
Best practice & research. Clinical gastroenterology
Death or overnight hospitalization
no changein humans1
1 study
Death or overnight hospitalization
no changein humans1
Colonoscopy was not clearly linked with death or overnight hospitalization in humans (narrow analysis) (RD = 0% (95% CI, -0.36% to 0.35%)).
“Screening colonoscopy patients had a 1.04% (95% CI, 0.74%-1.34%) risk of death or hospitalization within 30 days in the narrow analysis, similar to those with FIT [RD = 0% (95% CI, -0.36% to 0.35%)]”
Humansnarrow analysis30 days
Incidence of Serious Complications following Screening Colonoscopy in Adults Ages 76 to 85 Years
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Lifetime gained
no changein humans1
1 study
Lifetime gained
no changein humans1
Colonoscopy showed no clear effect on lifetime gained in humans (37 days (95% CI, -146 to 146 days)).
“colonoscopy (37 days; 95% CI, -146 to 146 days)”
Review10 years follow-up
Estimated Lifetime Gained With Cancer Screening Tests: A Meta-Analysis of Randomized Clinical Trials
JAMA internal medicine
Quality-adjusted life-years gained
upin silico1
1 study
Quality-adjusted life-years gained
upin silico1
Colonoscopy improves quality-adjusted life-years gained in silico (unscreened elderly persons with no comorbid conditions).
“Screening with colonoscopy was indicated up to age 83 years, sigmoidoscopy was indicated at age 84 years, and FIT was indicated at ages 85 and 86 years.”
In silicounscreened elderly persons with no comorbid conditions
Annals of internal medicine
What is colonoscopy linked with?
20Studies link colonoscopy with 20 measures, most often colorectal cancer (9 studies), colorectal polyp detection (2) and gastrointestinal bleeding (2).
Colorectal cancer
downin humans7upin humans2
9 studies
Colorectal cancer
downin humans7upin humans2
Colonoscopy lowers the risk of colorectal cancer in humans (healthy adults).
“The observed reductions in CRC-related mortality and CRC incidence, which were consistent across both screening strategies, were independent of sex or age.”
Human trialhealthy adults
United European gastroenterology journal
Colonoscopy is linked with a higher risk of colorectal cancer in humans (colonoscopic surveillance at a mean interval of ≤2 years).
“Colonoscopic surveillance at a mean interval of ≤2 years (n=1569) was associated with an increase in total CRC incidence.”
Humanscolonoscopic surveillance at a mean interval of ≤2 yearsn = 1,569
Gut
Colonoscopy is linked with a lower risk of colorectal cancer in humans (aHR 0.75, 95% CI 0.66-0.84).
“Colonoscopy was associated with a significantly reduced CRC risk among adults aged 75 to 79 years (aHR, 0.75; 95% CI, 0.66-0.84)”
Humans
Colonoscopy linked to lower colorectal cancer risk at ages 75–79
Gastrointestinal endoscopy
Colonoscopy is linked with a lower risk of colorectal cancer in humans (5.5 fewer cases (95% confidence interval: 1.44-9.56) per 1000 person-years, corresponding to a 45.5% reduction).
“After 10 years of follow-up, a reduction was seen between the groups from 12.1 to 6.6 cases per 1000 person-years, equivalent to 5.5 fewer cases (95% confidence interval: 1.44-9.56) per 1000 person-years”
Humans10 yearsn = 2,773
International journal of epidemiology
Colonoscopy is linked with a lower risk of colorectal cancer in humans after positive FOBT (SIR 0.52 (95% CI, 0.39-0.68)).
“Individuals with a negative screening colonoscopy result had a significantly lower observed CRC incidence (SIR, 0.52; 95% CI, 0.39-0.68) relative to the general population”
Humansafter positive FOBTcolorectaln = 8,433
Colorectal Cancer Risk With Negative Colonoscopy or Nonadherence After Positive FOBT Screening
JAMA network open
Colonoscopy is associated with colorectal cancer in humans (10 years after negative colonoscopy) (1.29% (95% CI, 1.02%-1.61%) at 8 years).
“with a cumulative incidence of 0.39% [95% CI, 0.31%-0.48%) at 2 years that increased to 1.29% (95% CI, 1.02%-1.61%) at 8 years.”
Humans10 years after negative colonoscopy8 years
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Colonoscopy lowers the risk of colorectal cancer in individuals with serrated polyposis syndrome.
“frequent surveillance colonoscopy is recommended to decrease incident CRC.”
Reviewin individuals with serrated polyposis syndrome
Gastrointestinal endoscopy
Colonoscopy lowers the risk of colorectal cancer in humans (reducing CRC incidence and mortality by up to 77% and 53%, respectively) (up to 77% and 53%).
“reducing CRC incidence and mortality by up to 77% and 53%, respectively”
Reviewreducing CRC incidence and mortality by up to 77% and 53%, respectively
Journal of clinical medicine
Colonoscopy lowers the risk of colorectal cancer in humans.
“polypectomy substantially reduces CRC incidence and mortality.”
Review
Screening for Colorectal Cancer with Colonoscopy
Gastrointestinal endoscopy clinics of North America
Colorectal polyp detection
upin humans2OR 2.27
2 studies
Colorectal polyp detection
upin humans2OR 2.27
Colonoscopy is associated with colorectal polyp detection in humans (Compared with symptomatic diagnostic colonoscopy; adjusted for age category and sex) (40.7% vs. 27.9%; adjusted OR 2.27 (95% CI 1.72–3.01)).
“Screening-indication colonoscopy showed higher overall polyp (40.7% vs. 27.9%)”
HumansCompared with symptomatic diagnostic colonoscopy; adjusted for age category and sexscreening-indicationn = 1,208
Frontiers in surgery
Colonoscopy is associated with colorectal polyp detection in humans (Propensity-matched adults with a colorectal cancer screening encounter) (HR 1.88, 95% CI 1.82–1.95).
“Colonoscopy increased polyp detection (HR 4.43 [95% CI 4.15-4.73] at 30 days; 1.88 [1.82-1.95] at 5 years)”
HumansPropensity-matched adults with a colorectal cancer screening encounterscreening5 years
Colonoscopy linked to more cancer detection in older adults
JGH open : an open access journal of gastroenterology and hepatology
Gastrointestinal bleeding
downin humans1upin humans1HR 0.9
2 studies
Gastrointestinal bleeding
downin humans1upin humans1HR 0.9
Colonoscopy is associated with gastrointestinal bleeding in humans (Propensity-matched adults with a colorectal cancer screening encounter) (HR 0.90, 95% CI 0.84–0.97).
“gastrointestinal bleeding fell at 1 year (HR 0.90 [0.84-0.97]; p = 0.004).”
HumansPropensity-matched adults with a colorectal cancer screening encounterscreening1 year
Colonoscopy linked to more cancer detection in older adults
JGH open : an open access journal of gastroenterology and hepatology
Colonoscopy is linked with a higher risk of gastrointestinal bleeding in humans (0.18% (95% CI, 0.09%-0.35%)).
“Patients undergoing screening colonoscopy (N = 4,435) had a higher 10-day cumulative incidence of gastrointestinal bleeding {0.18% [95% confidence interval (CI), 0.09%-0.35%]} and perforation [0.09% (95% CI, 0.03%-0.23%)]”
Humans10 days
Incidence of Serious Complications following Screening Colonoscopy in Adults Ages 76 to 85 Years
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Perforation
upin humans2HR 1.29
2 studies
Perforation
upin humans2HR 1.29
Colonoscopy is associated with perforation in humans (Propensity-matched adults with a colorectal cancer screening encounter) (HR 1.29, 95% CI 1.02–1.63).
“Perforation rose at 5 years (HR 1.29 [1.02-1.63]; p = 0.033)”
HumansPropensity-matched adults with a colorectal cancer screening encounterscreening5 years
Colonoscopy linked to more cancer detection in older adults
JGH open : an open access journal of gastroenterology and hepatology
Colonoscopy is linked with a higher risk of perforation in humans (0.09% (95% CI, 0.03%-0.23%)).
“Patients undergoing screening colonoscopy (N = 4,435) had a higher 10-day cumulative incidence of gastrointestinal bleeding {0.18% [95% confidence interval (CI), 0.09%-0.35%]} and perforation [0.09% (95% CI, 0.03%-0.23%)]”
Humans10 days
Incidence of Serious Complications following Screening Colonoscopy in Adults Ages 76 to 85 Years
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Mortality
mixedin humans1downin humans1HR 0.86
2 studies
Mortality
mixedin humans1downin humans1HR 0.86
Colonoscopy is associated with mortality in humans (Complete versus incomplete colonoscopy diagnostic process).
“death (p < 0.001) between patients who had a complete colonoscopy diagnostic process and those who did not.”
HumansComplete versus incomplete colonoscopy diagnostic process
The impact of incomplete colonoscopies: a single-centre retrospective study
Canadian journal of surgery. Journal canadien de chirurgie
Colonoscopy is linked with a lower risk of mortality in humans (comparing ever- to never-screening) (HR 0.86, 95% CI 0.75-0.99).
“hazard ratios (95% confidence intervals) for all-cause mortality comparing ever- to never-screening were 0.86 (0.75-0.99) for young individuals”
Humanscomparing ever- to never-screening
Cancer research and treatment
Colorectal cancer mortality
downin humans1upin humans1HR 0.52
2 studies
Colorectal cancer mortality
downin humans1upin humans1HR 0.52
Colonoscopy is linked with a lower risk of colorectal cancer mortality in humans (comparing ever- to never-screening) (HR 0.52, 95% CI 0.31-0.87).
“0.52 (0.31-0.87) for those aged ≥ 45 years.”
Humanscomparing ever- to never-screening
Cancer research and treatment
Colonoscopy is associated with colorectal cancer mortality in humans (10 years after negative colonoscopy) (0.46% (95% CI, 0.30%-0.70%) at 8 years).
“Cumulative mortality from colorectal cancer was 0.04% (95% CI, 0.02%-0.08%) at 2 years and 0.46% (95% CI, 0.30%-0.70%) at 8 years.”
Humans10 years after negative colonoscopy8 years
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Colorectal adenocarcinoma detection
downin humans1OR 0.15
1 study
Colorectal adenocarcinoma detection
downin humans1OR 0.15
Colonoscopy is associated with colorectal adenocarcinoma detection in humans (Compared with symptomatic diagnostic colonoscopy; adjusted for age category and sex) (0.2% vs. 1.9%; Firth adjusted OR 0.15 (95% CI 0.02–0.61)).
“symptomatic diagnostic examinations showed greater detection of conventional adenomas, large polyps, advanced precursor lesions, and adenocarcinoma.”
HumansCompared with symptomatic diagnostic colonoscopy; adjusted for age category and sexscreening-indicationn = 1,208
Frontiers in surgery
Colorectal cancer detection
upin humans1HR 1.78
1 study
Colorectal cancer detection
upin humans1HR 1.78
Colonoscopy is associated with colorectal cancer detection in humans (Propensity-matched adults with a colorectal cancer screening encounter) (HR 1.78, 95% CI 1.59–1.98).
“and colorectal cancer detection (4.56 [3.62-5.74]; 1.78 [1.59-1.98]; all p ≤ 0.003).”
HumansPropensity-matched adults with a colorectal cancer screening encounterscreening5 years
Colonoscopy linked to more cancer detection in older adults
JGH open : an open access journal of gastroenterology and hepatology
Colonic perforation
upin reviews1
1 study
Colonic perforation
upin reviews1
Colonoscopy raises the risk of colonic perforation (universal polypectomy strategy).
“which removes more pseudodisease and incurs excess risk of colonic perforation without benefit.”
Reviewuniversal polypectomy strategy
CT Colonography: Where Are We with Colorectal Cancer Screening?
Radiographics : a review publication of the Radiological Society of North America, Inc
Colorectal neoplasia
upin humans1+56%
1 study
Colorectal neoplasia
upin humans1+56%
Colonoscopy is associated with colorectal neoplasia in humans (56.1%).
“Colorectal neoplasia was identified at colonoscopy in over half of participants (56.1%)”
Humansn = 4,754
BMJ open gastroenterology
All 20Fewer
What acts on colonoscopy?
1Studies name Multivariable fractional-polynomial interaction model as acting on colonoscopy.
Multivariable fractional-polynomial interaction model
downin humans1
1 study
Multivariable fractional-polynomial interaction model
downin humans1
multivariable fractional-polynomial interaction model is linked with lower colonoscopy in humans (12% risk cutoff) (reducing colonoscopy volume by 48.4%).
“Using a 12% risk cutoff, one ACN was detected for every three colonoscopies, reducing colonoscopy volume by 48.4%.”
Humans12% risk cutoffn = 1,374
Journal of gastroenterology and hepatology
Funding
26 grants since 2010National Cancer Institute$21.9MUS Department of Veterans AffairsNational Institute of Diabetes and Digestive and Kidney Diseases$1.7M
Video-Based Bundle to Improve Screening Colonoscopy Quality in Lower-Volume Clinicians
National Institute of Diabetes and Digestive and Kidney DiseasesIndiana University Indianapolis$346K2026–2029
Rural Community Support for Colonoscopy
National Cancer InstituteUniversity of Washington$237K2021–2027
IMProving Adherence to Colonoscopy through Teams and Technology (IMPACTT)
National Cancer InstituteUniversity of California, San Francisco$665K2022–2027
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
US Department of Veterans AffairsVa San Diego Healthcare System2023–2027
National Cancer InstituteUniversity of California Los Angeles$612K2022–2027
National Cancer InstituteOhio State University$206K2023–2028
Evaluating the effectiveness of colonoscopy for colorectal cancer from receipt big data
Japan Society for the Promotion of ScienceKumamoto University¥4.6M2025–2028
National Institute for Health ResearchThe Chancellor Masters and Scholars of the University of Cambridge£454K2024–2026
ColoCompare: colonoscopy guidance and AI assisted procedure comparison
Norges Forskningsråd2024–2027
Single viewpoint panoramic imaging technology for colonoscopy
National Cancer InstituteUniversity of Arizona$165K2023–2025
Contains public sector information licensed under the Open Government Licence v3.0.
How this record changed
Summary rewritten as its findings changed.
As it read before
In human cohorts, colonoscopy associates with colorectal neoplasia detection. Reviews indicate it reduces colorectal cancer risk, including in individuals with serrated polyposis syndrome, while universal polypectomy strategies raise the risk of colonic perforation.
Summary written from the findings.